This case report adds to the literature suggesting that COVID-19 may potentially unmask the onset of CJD through the ‘S1’ spike protein promoting aggregation of prion proteins and SARS-CoV-2 induced pro-inflammatory microglial phenotype leading to neuroinflammation. The gene discussed is PRNP; the disease is COVID-19.